Clinical Trials on Osteoporosis, Postmenopausal in Spain

Total 62 results

Germans Trias i Pujol Hospital

Completed

Efficacy And Security Of Annual And Biennial Zoledronic Acid For Osteoporosis Treatment In An HIV-Infected Patients' Cohort

HIV Infections

Spain
Pfizer

Completed

Study Evaluating Changes In Bone Mineral Density (BMD), And Safety Of Rhbmp-2/CPM In Subjects With Decreased BMD

Osteoporosis

United States, Belgium, Spain, Poland
Novartis

Completed

Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis

Osteoporosis

United States, Belgium, Germany, Spain
Janssen Research & Development, LLC

Completed

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Postmenopausal | Metastatic ER+ Her2- Breast Cancer

United States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland
GlaxoSmithKline

Terminated

A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

Osteoporosis

Germany, Russian Federation, Korea, Republic of, United States, Belgium, Hong Kong, Spain, Australia, Argentina, South Africa, Poland, Norway, Mexico, Denmark
Vexim SA
ACES Ing.-GmbH

Completed

Prospective Comparative Study to Compare Safety and Effectiveness of Two Vertebral Compression Fracture Reduction Techniques (SAKOS)

Osteoporosis | Spinal Fractures | Back Injuries | Vertebral Compression Fractures

Spain, France, Switzerland, Germany, Italy
ETOP IBCSG Partners Foundation

Completed

Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98

Breast Cancer | Osteoporosis

France, Italy, Switzerland, Australia, Peru, Spain, New Zealand, South Africa
Teknimed

Recruiting

SPINE BONE CEMENTS OUTCOMES

Vertebral Fracture | Osteoporotic Fractures | Compression Fracture

Spain, France, Portugal, Ukraine
Ligand Pharmaceuticals

Completed

Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL) (PEARL)

Osteoporosis

United States, Australia, Canada, Costa Rica, Germany, Russian Federation, France, Croatia, South Africa, Belgium, Japan, India, Spain, United Kingdom, Italy, Egypt, Turkey, Lithuania, Poland, Norway, Estonia, Finland, Denmark, Hong Kong and more
Eli Lilly and Company

Completed

A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture (MOVE)

Osteoporosis

United States, Spain, France, Mexico, Italy, Greece, Croatia, Denmark, Germany, Czechia, Canada, Norway
Pfizer

Completed

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

Osteoporosis

United States, Canada, France, Greece, Germany, Argentina, Chile, Croatia, South Africa, Belgium, Italy, Spain, Australia, Bulgaria, Hong Kong, Poland, Finland, Slovakia, Russian Federation, Brazil, Norway, New Zealand, Lithuania, Est... and more
AgNovos Healthcare, LLC
Avania; BioClinica, Inc.; CMIC Co, Ltd. Japan; Emergent Clinical Consulting, LLC

Recruiting

RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

Hip Fractures | Osteoporosis | Fragility Fracture

Denmark, Spain, Netherlands, France, Germany, Japan, Italy, Austria, United Kingdom

Clinical Trials on Osteoporosis, Postmenopausal in Spain

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations